本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Syndax Pharmaceuticals, Inc.

13.70
+0.28002.09%
盤後13.700.00000.00%16:27 EDT
成交量:165.89萬
成交額:2,268.54萬
市值:11.79億
市盈率:-3.68
高:13.98
開:13.45
低:13.25
收:13.42
資料載入中...
2021/05/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/02

重要事件披露

8-K - Current report